Jacobson Center for Clinical and Translational Research
- JCCTR Home
- Current Clinical Trials
- Mentor Program
- Mission
- Research Opportunities and Support
- Research News
- Staff and Contacts
- TriNetX
- Office of Research
- Office of Senior Associate Dean of Research
- Research Library
- College of Medicine Home
- Medical Student Research
Contact Us
Health Science Campus
Center for Creative Education
2920 Transverse Drive, Floor 3,
Toledo, OH 43614
419.383.6919
ClinicalResearch@utoledo.edu
Studies at UToledo: Rheumatology
Study Title: A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis+ More Info
Identifier: NCT04478994
Study Purpose: The overall objective is to investigate the safety, tolerability and effect on insulin-like growth factor-1 (IGF-1), inflammatory and fibrotic biomarkers of TEPEZZA (teprotumumab-trbw, HZN-001), a fully human monoclonal antibody (mAb) inhibitor of the IGF-1 receptor (IGF-1R), administered once every 3 weeks (q3W) for 24 weeks in the treatment of participants with diffuse cutaneous systemic sclerosis (dcSSc).
Principal Investigator: Bashar Kahaleh, MD
Study Coordinator: Jennifer Gilmore, RN, BSN, CCRC, 419.383.6761